InspireMD
NSPR
23 hedge funds and large institutions have $20.2M invested in InspireMD in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
19,320% more capital invested
Capital invested by funds: $104K → $20.2M (+$20.1M)
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
53% more funds holding
Funds holding: 15 → 23 (+8)
36.93% more ownership
Funds ownership: 1.08% → 38.01% (+37%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$2.96M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.96M |
| 3 |
O
OrbiMed
New York
|
+$2.96M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.19M |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$1.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$14K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$890 |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$89 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Bank of America
Charlotte,
North Carolina
| – | -$1 | -1 | Closed |
|
NSPR Hedge Fund Activity: Q2 2023 in Review
23 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q2 2023, worth a combined $20.2M — up 19,320% from $104K a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new NSPR positions and 3 closed out — a net gain of 8 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $2.96M. The largest seller was Millennium Management, exiting entirely with an estimated $14K sold.
- 23 institutional investors held InspireMD (NSPR) as of Q2 2023, up from 15 in Q1 2023.
- Funds reported $20.2M of InspireMD stock for Q2 2023, up 19,320% quarter-over-quarter.
- 11 funds opened new InspireMD positions in Q2 2023 and 3 closed out, a net change of +8 holders.
- The largest InspireMD buyer in Q2 2023 was Marshall Wace, an estimated $2.96M added.
- The largest InspireMD seller in Q2 2023 was Millennium Management, an estimated $14K sold.
Based on aggregated 13F filings for Q2 2023.